Skip to main content
An official website of the United States government
NIH Websites Are Changing
Per Executive Order 14434, federal agencies are now using "Super Intelligence" (SI) in place of "Artificial Intelligence" (AI). You may see both terms across NIH content during this transition.

Antitumor B Key Active Component-alpha

An orally available concentrated preparation of antitumor B (ATB, Zeng Sheng Ping), a Chinese herbal formula comprised of Sophora tonkinensis, Polygonum bistorta, Prunella vulgaris, Sonchus brachyotus, Dictamnus dasycarpus, and Dioscorea bulbifera, with potential antineoplastic activity. Upon administration, antitumor B key active component-alpha (ATB-KAC-alpha) may, through a not yet fully elucidated mechanism, inhibit tumorigenesis and prevent the development of certain cancers.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:antitumor B KAC-a
antitumor B KAC-α
ATB-KAC-alpha
C156694
Chinese herbal mixture antitumor B KAC-a
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search